ARID1A-mutated Ovarian Cancers Depend on HDAC6 Activity

Nature Cell Biology - United Kingdom
doi 10.1038/ncb3582
Full Text
Abstract

Available in full text

Categories
Cell Biology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

MCC (Mutated in Colorectal Cancers)

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2014English

Capivasertib Active Against AKT1-Mutated Cancers

Cancer Discovery
Oncology
2018English

Histone Deacetylase Inhibition Has Targeted Clinical Benefit in ARID1A Mutated Advanced Urothelial Carcinoma

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

Targeting the Vulnerability of Glutathione Metabolism in ARID1A-Deficient Cancers

Cancer Cell
Cancer ResearchOncologyCell Biology
2019English

BGB-283, a Novel RAF Kinase and EGFR Inhibitor, Displays Potent Antitumor Activity in BRAF-Mutated Colorectal Cancers

Molecular Cancer Therapeutics
Cancer ResearchOncology
2015English

Cardiac HDAC6 Catalytic Activity Is Induced in Response to Chronic Hypertension

Journal of Molecular and Cellular Cardiology
Cardiovascular MedicineMolecular BiologyCardiology
2011English

Generation of a Selectively Cytotoxic Fusion Protein Against P53 Mutated Cancers

BMC Cancer
Cancer ResearchOncologyGenetics
2012English

ARID1A Mutations and PI3K/AKT Pathway Alterations in Endometriosis and Endometriosis-Associated Ovarian Carcinomas

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2013English

Inhibition of HDAC6 Activity Protects Dopaminergic Neurons From Alpha-Synuclein Toxicity

Scientific Reports
Multidisciplinary
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy